BRCA1 Immunohistochemistry in a Molecularly Characterized Cohort of Ovarian High-Grade Serous Carcinomas

American Journal of Surgical Pathology - United States
doi 10.1097/pas.0b013e31826cabbd
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Low-Stage High-Grade Serous Ovarian Carcinomas

International Journal of Gynecological Pathology
GynecologyForensic MedicinePathologyObstetrics
2016English

Serous Tubal Intraepithelial Carcinomas Associated With High-Grade Serous Ovarian Carcinomas: A Systematic Review

BJOG: An International Journal of Obstetrics and Gynaecology
GynecologyObstetrics
2017English

Clinico‑morphological Aspects and New Immunohistochemistry Characteristics of Ovarian High‑grade Serous Carcinoma

Archives of the Balkan Medical Union
Medicine
2018English

PAX2 Expression in Low Malignant Potential Ovarian Tumors and Low-Grade Ovarian Serous Carcinomas

Modern Pathology
Forensic MedicinePathology
2009English

New in High Grade Serous Ovarian Cancer Treatment

Effective Pharmacotherapy
2019English

HMGA2: A Biomarker Significantly Overexpressed in High-Grade Ovarian Serous Carcinoma

Modern Pathology
Forensic MedicinePathology
2010English

PARP Inhibitors in Platinum-Sensitive High-Grade Serous Ovarian Cancer

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2018English

BRCA1 and BRCA2 Mutations Correlate With TP53 Abnormalities and Presence of Immune Cell Infiltrates in Ovarian High-Grade Serous Carcinoma

Modern Pathology
Forensic MedicinePathology
2012English

Molecular Response to Neoadjuvant Chemotherapy in High-Grade Serous Ovarian Carcinoma

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy